Efficacy News and Research

RSS
German BfArM grants Moberg Derma approval to initiate Limtop phase II actinic keratosis trial

German BfArM grants Moberg Derma approval to initiate Limtop phase II actinic keratosis trial

Grape-derived compound may prevent neurodegenerative disorders involving tau neuropathology

Grape-derived compound may prevent neurodegenerative disorders involving tau neuropathology

Biosynthetic polyphenol may improve cognitive function in Alzheimer's disease patients

Biosynthetic polyphenol may improve cognitive function in Alzheimer's disease patients

Lenalidomide and SNS01-T combination effective against multiple myeloma

Lenalidomide and SNS01-T combination effective against multiple myeloma

Array BioPharma third quarter revenue increases to $19.1M

Array BioPharma third quarter revenue increases to $19.1M

Vessix V2 Renal Denervation System for hypertension receives CE Mark approval

Vessix V2 Renal Denervation System for hypertension receives CE Mark approval

InSite Vision first quarter total revenues decrease to $2.3 million

InSite Vision first quarter total revenues decrease to $2.3 million

Gilead commences GS-1101 Phase 3 trial in CLL

Gilead commences GS-1101 Phase 3 trial in CLL

ACE inhibitors or ARBs could treat and prevent PTSD

ACE inhibitors or ARBs could treat and prevent PTSD

Pfizer receives FDA approval for Elelyso to treat Type 1 Gaucher disease

Pfizer receives FDA approval for Elelyso to treat Type 1 Gaucher disease

Antibiotic effective for plague gets FDA nod

Antibiotic effective for plague gets FDA nod

Some public health advocates disagree with Indian government's decision to roll out pentavalent vaccines, IPS reports

Some public health advocates disagree with Indian government's decision to roll out pentavalent vaccines, IPS reports

CR2 announces acquisition of CardioReady

CR2 announces acquisition of CardioReady

FDA approves Levaquin for plague

FDA approves Levaquin for plague

Enrollment complete in Zalicus Synavive Phase 2b clinical trial for rheumatoid arthritis

Enrollment complete in Zalicus Synavive Phase 2b clinical trial for rheumatoid arthritis

Pharmanest commences SHACT Phase I pharmacokinetic study

Pharmanest commences SHACT Phase I pharmacokinetic study

VIVUS receives FDA approval for Stendra to treat erectile dysfunction

VIVUS receives FDA approval for Stendra to treat erectile dysfunction

Five U.S. federal agencies provide significant contributions each year to global health R&D

Five U.S. federal agencies provide significant contributions each year to global health R&D

FDA approves VIVUS’ STENDRA for treatment of erectile dysfunction

FDA approves VIVUS’ STENDRA for treatment of erectile dysfunction

Cameron Health's subcutaneous ICD for sudden cardiac arrest receives FDA advisory panel approval

Cameron Health's subcutaneous ICD for sudden cardiac arrest receives FDA advisory panel approval

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.